← Back to headlines
Outlook Therapeutics Targets Ophthalmology Market with New Drug After FDA Rejection
Outlook Therapeutics is aiming for the multibillion-dollar ophthalmology market with a new drug, following a previous rejection by the FDA.
28 Jul, 21:31 — 28 Jul, 21:31
Sources
Showing 1 of 1 sources
Related Stories
Philippine Lawmakers File Bills Against Electric System Loss Charges
just now
Philippine LTO Extends Permit Validity Amid Technical Issues
just now
Philippines DOTr Aims for Partial Common Station Operations by Q1 2028
just now
EFCC Boss Highlights Contract Fraud as Most Prevalent Corruption in Nigerian Public Sector
just now